Kidney enlargement resulting from the expansion of cysts in patients with ADPKD is continuous and quantifiable and is associated with the decline of renal function. Higher rates of kidney enlargement are associated with a more rapid decrease in renal function.
Similar to previously reported studies, PDAC with a KRAS wild type mutational profile has a better prognosis with a longer OS. This improved prognosis is…
ClinicalTrials.gov Identifier: NCT04248023.
For idiopathic pulmonary fibrosis (IPF), interleukin 11 (IL-11) is a pivotal cytokine that stimulates the transformation of fibroblasts into myofibroblasts, thus accelerating the progression of…
Recent research highlights the rising prevalence of AFMR, now accounting for nearly one-third of significant mitral regurgitation cases. Advances in percutaneous treatment options have improved…
Join me at #kdigogdgems – A virtual event covering ANCA vasculitis, complement-mediated kidney disease, IgA nephropathy and lupus nephritis
Steatotic liver disease is the overarching term for conditions characterised by abnormal lipid accumulation in the liver (liver or hepatic steatosis). Steatotic liver disease encompasses…
The accumulation of immune-suppressive myeloid cells is a critical determinant of resistance to anti-programmed death-1 (PD-1) therapy in advanced clear cell renal cell carcinoma (ccRCC).…
Concise, readable, and well-illustrated, Handbook of Glomerulonephritis is a convenient, one-stop resource for physicians, residents and fellows, advanced practice professionals, and nurses who are involved…
Olaparib for BRCA mutant pancreas cancer: Should the POLO trial change clinical practice?
